Chronic Physical Effects and Health Care Utilization in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group Study Enrichment based on molecular characteristics has emerged as an ...
NEW YORK--(BUSINESS WIRE)--Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today introduced Medidata Balance ™, a new randomization and trial ...
ANN ARBOR, Mich. — It's a classic Catch-22: Medical researchers need to figure out if a promising new treatment is truly better than a current one, by randomly assigning half of a group of patients to ...
Chronic Physical Effects and Health Care Utilization in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group Study Enrichment based on molecular characteristics has emerged as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results